The US FDA has cleared the bio-integrative technology from Israel’s Ossio (see here previously) to be used in orthopedic surgery for children and adolescents needing bone realignments, fusions or fracture fixation.
https://www.businesswire.com/news/home/20231206064383/en/OSSIO